Cholesterol depletion enhances adrenergic signaling in cardiac myocytes

Biochimica et Biophysica Acta - Biomembranes

Volumn 1808, Issue 1, 2011, Pages 461-465

  Paila, Yamuna Devi ^a   Jindal, Ekta ^b   Goswami, Shyamal K ^b   Chattopadhyay, Amitabha ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Adrenergic receptors; Adrenergic signaling; Cholesterol depletion; Cholesterol replenishment; H9c2 cardiac myocytes; M CD

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CHOLESTEROL; NORADRENALIN; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR FRA 1;

ADRENERGIC ACTIVITY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL DEPLETION; CONTROLLED STUDY; DEPLETION; EMBRYO; GENE EXPRESSION; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CHOLESTEROL; LIGANDS; LUCIFERASES; MODELS, GENETIC; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RECEPTORS, ADRENERGIC; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 78649803915     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.09.006     Document Type: Article

References (47)

1. K. Simons, and E. Ikonen How cells handle cholesterol Science 290 2000 1721 1725
2. O.G. Mouritsen, and M.J. Zuckermann What's so special about cholesterol? Lipids 39 2004 1101 1113
3. S. Mukherjee, and F.R. Maxfield Membrane domains Annu. Rev. Cell Dev. Biol. 20 2004 839 866
4. M. Edidin Shrinking patches and slippery rafts: scales of domains in the plasma membrane Trends Cell Biol. 11 2001 492 496
5. S. Munro Lipid rafts: elusive or illusive? Cell 115 2003 377 388
6. K. Jacobson, O.G. Mouritsen, and R.G.W. Anderson Lipid rafts: at a crossroad between cell biology and physics Nat. Cell Biol. 9 2007 7 14
7. D. Lingwood, and K. Simons Lipid rafts as a membrane-organizing principle Science 327 2010 46 50
8. J. Riethmüller, A. Riehle, H. Grassmé, and E. Gulbins Membrane rafts in host-pathogen interactions Biochim. Biophys. Acta 1758 2006 2139 2147
9. T.J. Pucadyil, and A. Chattopadhyay Cholesterol: a potential therapeutic target in Leishmania infection? Trends Parasitol. 23 2007 49 53
10. K. Burger, G. Gimpl, and F. Fahrenholz Regulation of receptor function by cholesterol Cell. Mol. Life Sci. 57 2000 1577 1592
11. T.J. Pucadyil, and A. Chattopadhyay Role of cholesterol in the function and organization of G-protein coupled receptors Prog. Lipid Res. 45 2006 295 333
12. Y.D. Paila, and A. Chattopadhyay Membrane cholesterol in the function and organization of G-protein coupled receptors Subcell. Biochem. 51 2010 439 466
13. K.L. Pierce, R.T. Premont, and R.J. Lefkowitz Seven-transmembrane receptors Nat. Rev. Mol. Cell Biol. 3 2002 639 650
14. D.M. Rosenbaum, S.G.F. Rasmussen, and B.K. Kobilka The structure and function of G-protein-coupled receptors Nature 459 2009 356 363
15. Y. Zhang, M.E. DeVries, and J. Skolnick Structure modeling of all identified G protein-coupled receptors in the human genome PLoS Comput. Biol. 2 2006 88 99
16. R. Heilker, M. Wolff, C.S. Tautermann, and M. Bieler G-protein-coupled receptor-focused drug discovery using a target class platform approach Drug Discov. Today 14 2009 231 240
17. S. Schlyer, and R. Horuk I want a new drug: G-protein-coupled receptors in drug development Drug Discov. Today 11 2006 481 493
18. S. Gupta, B. Das, and S. Sen Cardiac hypertrophy: mechanisms and therapeutic opportunities Antioxid. Redox Signal. 9 2007 623 652
19. Y. Lee, and A.B. Gustafsson Role of apoptosis in cardiovascular disease Apoptosis 14 2009 536 548
20. C. Communal, K. Singh, D.R. Pimentel, and W.S. Colucci Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway Circulation 98 1998 1329 1334
21. M.K. Gupta, T.V. Neelakantan, M. Sanghamitra, R.K. Tyagi, A. Dinda, S. Maulik, C.K. Mukhopadhyay, and S.K. Goswami An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts Antioxid. Redox Signal. 8 2006 1081 1092
22. J. Palomeque, L. Delbridge, and M.V. Petroff Angiotensin II: a regulator of cardiomyocyte function and survival Front. Biosci. 14 2009 5118 5133
23. G.W. Dorn, and S.B. Liggett Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure Mol. Pharmacol. 76 2009 466 480
24. J.S. Floras Sympathetic nervous system activation in human heart failure: clinical implications of an updated model J. Am. Coll. Cardiol. 54 2009 375 385
25. M. Bacaner, J. Brietenbucher, and J. LaBree Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease? Am. J. Ther. 11 2004 366 411
26. 1A receptors from bovine hippocampus Biochim. Biophys. Acta 1663 2004 188 200
27. G. Gimpl, V. Wiegand, K. Burger, and F. Fahrenholz Cholesterol and steroid hormones: modulators of oxytocin receptor function Prog. Brain Res. 139 2002 43 55
28. P.M. Burch, Z. Yuan, A. Loonen, and N.H. Heintz An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry Mol. Cell. Biol. 24 2004 4696 4709
29. 1A receptor in the plasma membrane of living cells Biochim. Biophys. Acta 1768 2007 655 668
30. 1A receptors Biochem. Biophys. Res. Commun. 389 2009 333 337
31. 1A receptors Biochemistry 49 2010 5426 5435
32. D.M. Amundson, and M. Zhou Fluorometric method for the enzymatic determination of cholesterol J. Biochem. Biophys. Methods 38 1999 43 52
33. R. Zidovetzki, and I. Levitan Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies Biochim. Biophys. Acta 1768 2007 1311 1324
34. A. Woehler, and E.G. Ponimaskin G protein-mediated signaling: same receptor, multiple effectors Curr. Mol. Pharmacol. 2 2009 237 248
35. G.M. Kuster, D.R. Pimentel, T. Adachi, Y. Ido, D.A. Brenner, R.A. Cohen, R. Liao, D.A. Siwik, and W.S. Colucci Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras Circulation 111 2005 1192 1198
36. 2-adrenoceptor signaling is dictated by GRK2 phosphorylation in cardiomyocytes J. Biol. Chem. 283 2008 1799 1807
37. Y.D. Paila, and A. Chattopadhyay The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction ? Glycoconj. J. 26 2009 711 720
38. Y.D. Paila, S. Tiwari, and A. Chattopadhyay Are specific nonannular cholesterol binding sites present in G-protein coupled receptors ? Biochim. Biophys. Acta 1788 2009 295 302
39. H. Ohvo-Rekila, B. Ramstedt, P. Leppimaki, and J.P. Slotte Cholesterol interactions with phospholipids in membranes Prog. Lipid Res. 41 2002 66 97
40. 1A receptor: a representative member of the serotonin receptor family Cell. Mol. Neurobiol. 25 2005 553 580
41. B. Lei, D.P. Morris, M.P. Smith, and D.A. Schwinn Lipid rafts constrain basal alpha(1A)- adrenergic receptor signaling by maintaining receptor in an inactive conformation Cell. Signal. 21 2009 1532 1539
42. 2- adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction J. Biol. Chem. 283 2008 24659 24672
43. 2 adrenoceptor in detergent micelles Anal. Biochem. 343 2005 344 346
44. 2- adrenergic G protein-coupled receptor Science 318 2007 1258 1265
45. 2-adrenergic receptor Structure 16 2008 897 905
46. S.H. Lin, and O. Civelli Orphan G protein-coupled receptors: targets for new therapeutic interventions Ann. Med. 36 2004 204 214
47. C.A. Taira, A. Carranza, M. Mayer, C. Di Verniero, J.A. Opezzo, and C. Höcht Therapeutic implications of β-adrenergic receptor pharmacodynamic properties Curr. Clin. Pharmacol. 3 2008 174 184